• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

IDEXX Laboratories (IDXX)

Common Shares
Sell: $540.93|Buy: $565.50|Change: 21.75 (-3.72%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ inthe office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Address

One IDEXX Drive
Westbrook
ME
USA
04092

Telephone

+1 207 5560300

Website

https://www.idexx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
IDEXX Laboratories Inc Annual Report for 20262027-02-19T00:00:00
IDEXX Laboratories Inc Fourth Quarter Earnings Conference Call for 20262027-02-02T08:30:00
IDEXX Laboratories Inc Fourth Quarter Earnings Results for 20262027-02-02T00:00:00
IDEXX Laboratories Inc Third Quarter Earnings Conference Call for 20262026-11-03T08:30:00
IDEXX Laboratories Inc Third Quarter Earnings Results for 20262026-11-03T00:00:00
IDEXX Laboratories Inc Second Quarter Earnings Conference Call for 20262026-08-04T08:30:00
IDEXX Laboratories Inc Second Quarter Earnings Results for 20262026-08-04T00:00:00
IDEXX Laboratories Inc Annual General Meeting for 20262026-05-12T10:00:00
IDEXX Laboratories Inc First Quarter Earnings Conference Call for 20262026-05-05T08:30:00
IDEXX Laboratories Inc First Quarter Earnings Result for 20262026-05-05T00:00:00

Previous key dates

NameKey Date
47th Annual Raymond James Institutional Investors Conference2026-03-02T09:15:00
virtual BofA Securities Animal Health Summit2026-02-26T09:55:00
IDEXX Laboratories Inc Annual Report for 20252026-02-20T00:00:00
IDEXX Laboratories Inc Fourth Quarter Earnings Conference Call for 20252026-02-02T08:30:00
IDEXX Laboratories Inc Fourth Quarter Earnings Results for 20252026-02-02T00:00:00
IDEXX Laboratories Inc Third Quarter Earnings Conference Call for 20252025-11-03T08:30:00
IDEXX Laboratories Inc Third Quarter Earnings Result for 20252025-11-03T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T13:50:00
IDEXX Laboratories Inc Second Quarter Earnings Conference Call for 20252025-08-04T08:30:00
IDEXX Laboratories Inc Second Quarter Earnings Result for 20252025-08-04T00:00:00
Stifel Jaws & Paws Conference2025-05-28T10:55:00
2025 Investor Day2025-05-14T08:00:00
IDEXX Laboratories Inc Annual General Meeting for 20252025-05-07T10:00:00
IDEXX Laboratories Inc First Quarter Earnings Conference Call for 20252025-05-01T08:30:00
IDEXX Laboratories Inc First Quarter Earnings Result for 20252025-05-01T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.